Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.1.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.160.31ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.160.31ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.160.31ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.160.31NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.385ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.385ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.385ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.385NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.384ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.384ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.384ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.384NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.160.32ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.160.32ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.160.32ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.160.32NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.338ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.338ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.338ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.338NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BG.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BG.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BG.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BG.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.20.1 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.20.1 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.20.1 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.20.1 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XVORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XVENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XVENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XVNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.38.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.38.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.38.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.38.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.4.1.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.4.1.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.4.1.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.1.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.80ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.80ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.80ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.80NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.134ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.134ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.134ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.134NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CZ.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used